Qinghai Red Cross Hospital
11
5
5
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
36%
4 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
Role: lead
Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain
Role: lead
HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
Role: collaborator
Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
Role: lead
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
Role: lead
Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy
Role: lead
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Role: lead
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
Role: collaborator
Establishing the Reference Interval for Pulse Oxygen Saturation in Neonates at High Altitude
Role: collaborator
Effects of Esketamine on Postpartum Depression
Role: collaborator
POX Range and the Threshold for Screening Major CHD in Neonates at Different Altitudes
Role: collaborator
All 11 trials loaded